Publications by authors named "Mark Eccleston"

Claim this Profile
P
Precision epigenetic therapies in oncology.
Arundhati Chaudhary, Kayleigh J A Orchard, Francesca Salani, Theodora Partsou, Mark Eccleston

Cancer Metastasis Rev· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines.
Maryam Latarani, Perla Pucci, Mark Eccleston, Massimiliano Manzo, Priyadarsini Gangadharannambiar

Epigenomics· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid high-throughput method for investigating physiological regulation of neutrophil extracellular trap formation.
Kieran Zukas, Justin Cayford, Finley Serneo, Brandi Atteberry, Andrew Retter, Mark Eccleston

J Thromb Haemost· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma.
Priscilla Van den Ackerveken, Alison Lobbens, Dorian Pamart, Aristotelis Kotronoulas, Guillaume Rommelaere, Mark Eccleston

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib.
Francesca Salani, Maryam Latarani, Andrea Casadei-Gardini, Priyadarsini Gangadharannambiar, Lorenzo Fornaro, Mark Eccleston

Epigenomics· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression.
Etienne Cavalier, Julien Guiot, Katharina Lechner, Alexander Dutsch, Mark Eccleston

Front Mol Biosci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 inhibition: a promising strategy to prevent cancer immune editing.
Ning Kang, Mark Eccleston, Pier-Luc Clermont, Maryam Latarani, David Kingsley Male

Epigenomics· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Academia Meets Industry.
Christian Schäfer, Tobias Paprotka, Ellen Heitzer, Mark Eccleston, Johannes Noe

Adv Exp Med Biol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer.
Monika Bauden, Dorian Pamart, Daniel Ansari, Marielle Herzog, Mark Eccleston

Clin Epigenetics· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer diagnostic options: Past, present, and future.
Mark E Eccleston

MLO Med Lab Obs· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of L-leucine graft content on aqueous solution behavior and membrane-lytic activity of a pH-responsive pseudopeptide.
Rongjun Chen, Sariah Khormaee, Mark E Eccleston, Nigel K H Slater

Biomacromolecules· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of hydrophobic amino acid grafts in the enhancement of membrane-disruptive activity of pH-responsive pseudo-peptides.
Rongjun Chen, Sariah Khormaee, Mark E Eccleston, Nigel K H Slater

Biomaterials· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aqueous solution behaviour and membrane disruptive activity of pH-responsive PEGylated pseudo-peptides and their intracellular distribution.
Rongjun Chen, Zhilian Yue, Mark E Eccleston, Nigel K H Slater

Biomaterials· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
ValiRx plc.
Mark Eccleston, George Morris

Per Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence intensity and lifetime imaging of free and micellar-encapsulated doxorubicin in living cells.
Xiaowen Dai, Zhilian Yue, Mark E Eccleston, Johannes Swartling, Nigel K H Slater

Nanomedicine· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of the pH-responsive properties of poly(L-lysine iso-phthalamide) grafted with a poly(ethylene glycol) analogue.
Zhilian Yue, Mark E Eccleston, Nigel K H Slater

Biomaterials· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of cell membrane disruption by pH-responsive pseudo-peptides through grafting with hydrophilic side chains.
Rongjun Chen, Zhilian Yue, Mark E Eccleston, Sharon Williams, Nigel K H Slater

J Control Release· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affinity capture of a biotinylated retrovirus on macroporous monolithic adsorbents: towards a rapid single-step purification process.
Sharon L Williams, Mark E Eccleston, Nigel K H Slater

Biotechnol Bioeng· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis